STEPHEN SALLOWAY

My research focuses on the following areas: clinical trials for the prevention and treatment of Alzheimer's disease, mild cognitive impairment, and vascular dementia; studies of genetic and sporadic forms of microvascular brain disease; studies of executive function and frontal behaviors; and the development of imaging biomarkers to study conversion to dementia.

Overview  |  Grants/Awards  |  Teaching  |  Publications

Biography

Stephen Salloway, MD, MS, is Director of Neurology and the Memory and Aging Program at Butler Hospital in Providence, Rhode Island, and Professor of Clinical Neurosciences and Psychiatry at Brown Medical School. He is the Director of the Brown Combined Residency in Neurology and Psychiatry and Codirector of the National Institute on Aging-sponsored Brown Dementia Research Fellowship Program. He received his MD from Stanford Medical School and completed residencies in neurology and psychiatry at Yale University.

Dr. Salloway has published more than 185 scientific articles, book chapters, and abstracts and has edited 3 books. His research focuses on the following areas: clinical trials for the prevention and treatment of Alzheimer's disease, mild cognitive impairment, and vascular dementia; studies of genetic and sporadic forms of microvascular brain disease; studies of executive function and frontal behaviors; and the development of imaging biomarkers to study conversion to dementia. Dr. Salloway has received numerous grants for his research from the National Institutes of Health and from private foundations. He published the first controlled clinical trials of cholinesterase inhibitors for the treatment of mild cognitive impairment and vascular dementia. Under his direction, the Butler Memory and Aging Program has become a nationally recognized clinical research center that tests new disease-modifying treatments for Alzheimer's disease, including amyloid vaccines, gamma secretase inhibitors and modulators, antifibrillization agents, and RAGE inhibitors. His program has also become a key research center in the United States for the study of CADASIL, a genetic disorder that causes stroke and vascular dementia.

Dr. Salloway is a past president of the American Neuropsychiatric Association, a fellow of the American Academy of Neurology, and a member of the American Neurological Association. He is a scientific reviewer for the National Institutes of Health and for more than 30 journals, universities, and research foundations. Dr. Salloway lectures widely on dementia and he is a leading proponent of the early diagnosis and treatment of Alzheimer's disease.

Curricum Vitae

Download Stephen Salloway's Curriculum Vitae in PDF Format

STEPHEN SALLOWAY, MD, MS
Professor of Neurology
Neurology
Phone: +1 401 455 6403
E-mail: Stephen_Salloway@Brown.EDU

Stephen Salloway's Brown Research URL:
http://research.brown.edu/myresearch/Stephen_Salloway

On The Web:
Memory and Aging Program

Brown collaborators:

Collaborators at other institutions:
Keith Johnson
Reisa Sperling

Are you Stephen Salloway? Click here to edit your research profile.

Back to search page

Research at Brown: The Directory of Research and Researchers: Research Profile
Brown.edu Brown Research home page
Contact Us Search